Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1988-05-11
1990-05-29
Garvin, Patrick P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514513, 514522, 514529, 514532, 514540, 514562, 562426, 562427, 562432, 560 10, 560 16, 560 17, 560 18, 564153, 564154, 558254, 558417, C07C14940, C07C15600, C07C15709
Patent
active
049296418
ABSTRACT:
Novel mercapto-acylamino acids useful in the treatment of hypertension and combinations of mercapto-acylamino acids and atrial natriuretic factors or angiotensin converting enzyme inhibitors useful for treating hypertension are disclosed.
REFERENCES:
patent: 4053651 (1977-10-01), Ondetti et al.
patent: 4228077 (1980-10-01), Ondetti et al.
patent: 4329495 (1982-05-01), Bindra
patent: 4401677 (1983-04-01), Greenberg et al.
patent: 4500467 (1985-02-01), Kubinyi et al.
patent: 4513009 (1985-04-01), Roques et al.
patent: 4740499 (1988-04-01), Olins
patent: 4801609 (1989-01-01), Haslanger et al.
Needleman et al, N. Eng. J. Med., 314, 13 (1986), pp. 828-834.
Cantin et al., Scientific American, 254 (1986), pp. 76-81.
Haslanger Martin F.
Neustadt Bernard R.
Smith Elizabeth M.
Garvin Patrick P.
Irzinski E. D.
Magatti Anita W.
Miller Stephen I.
Nelson James R.
LandOfFree
Mercapto-acylamino acid antihypertensives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mercapto-acylamino acid antihypertensives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mercapto-acylamino acid antihypertensives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-521303